Analyst Coverage

Submenu

Firm	Analyst
Barclays	Peter Lawson, DPhil (Oxon)
BofA Securities	Jason Zemansky, Ph.D.
Brookline Capital Markets	Leah Cann
BTIG	Justin Zelin
Cantor Fitzgerald	Li Watsek
H.C. Wainwright & Co.	Joseph Pantginis, Ph.D.
Jefferies	Roger Song, M.D., CFA
JMP Securities	Reni Benjamin, Ph.D.
Leerink Partners	Jonathan Chang, Ph.D., CFA
LifeSci Capital	Charles Zhu, Ph.D.
Mizuho Securities	Salim Syed
Scotia Capital (USA)	George Farmer, Ph.D.
Stifel	Brad Canino
TD Cowen	Phil Nadeau, Ph.D.
UBS	David Dai
Wedbush	Robert Driscoll, Ph.D.

Kura Oncology, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Kura Oncology, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kura Oncology, Inc. or its management. Kura Oncology, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121